Biotech Updates

Scientists to Improve Disease Resistance of Sweet Oranges

October 8, 2014

Brazilian scientists led by Lisia Atillo studied the genetic transformation of sweet oranges through the use of Salicylic binding-protein 2 (SABP2) to enhance the resistance of sweet oranges to citrus-diseases such as leprosies, citrus canker, and greening disease (HLB). SABP2 is involved in signal transduction pathway which activates systemic resistance and can enhance disease resistance of sweet oranges, thus overexpressing it in this crop can be a tool in enhancing sweet oranges' resistance to diseases.

Results of the study show that the overexpression of SABP2 had resulted to the production of transgenic shoots. This transgenic shoots are then grafted to Carrizo citrange, a sweet orange cultivar to further assess and evaluate its resistance to citrus diseases.

Further details of the study can be read at: http://www.biomedcentral.com/1753-6561/8/S4/P109.